WASHINGTON, June 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to FitRX LLC dba AM RX from its Center for Drug Evaluation and Research:

* * *

Recipient: Kyle Robertson, Founder & Chief Executive Officer, FitRX, LLC dba AM RX, 30 Irving Pl, New York, NY 10003, United States, support@getamrx.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States